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ABSTRACT

ARTICLE HISTORY

Purpose: A European network was initiated in 2012 by 23 partners from 16 European countries with
the aim to significantly increase individualized dose reconstruction in case of large-scale radiological
emergency scenarios.
Results: The network was built on three complementary pillars: (1) an operational basis with seven
biological and physical dosimetric assays in ready-to-use mode, (2) a basis for education, training and
quality assurance, and (3) a basis for further network development regarding new techniques and
members. Techniques for individual dose estimation based on biological samples and/or inert personalized devices as mobile phones or smart phones were optimized to support rapid categorization of
many potential victims according to the received dose to the blood or personal devices.
Communication and cross-border collaboration were also standardized. To assure long-term sustainability of the network, cooperation with national and international emergency preparedness organizations
was initiated and links to radiation protection and research platforms have been developed. A legal
framework, based on a Memorandum of Understanding, was established and signed by 27 organizations by the end of 2015.
Conclusions: RENEB is a European Network of biological and physical-retrospective dosimetry, with the
capacity and capability to perform large-scale rapid individualized dose estimation. Specialized to handle large numbers of samples, RENEB is able to contribute to radiological emergency preparedness
and wider large-scale research projects.
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Introduction
Over the last years, the risk of a large-scale radiological event
has markedly increased, not only due to possible accidents in
nuclear facilities but particularly as a result of the threat of
terrorist attacks against key facilities or civil targets in major
cities. According to the judgement of the Central Intelligence
Agency (CIA) in 2003, terrorist groups are willing to produce
nuclear weapons and also are able to construct a radiological
dispersal device (RDD) or an explosive RDD (‘dirty bomb’)
(CIA 2003). The CIA assessment was that the use of such RDD
could have consequences for health, environment and economy, but also could have political and social effects due to
fear, injury and costly and time-consuming clean-up efforts,
even if the factual damage of the RDD could be comparatively small. In 2010 the report ‘Foresight into needs, possibilities and information requirements for the future’ of the EU
project ‘MASH – Mass casualties and health care following
the release of toxic chemicals or radioactive material’ (Baker
et al. 2010) declared it prudent to plan for the response to a
mass emergency involving toxic or radioactive materials as
such an eventuality may develop at a rate and reach a magnitude sufficient to impose a major crisis on society. In this
context the establishment and maintenance of a Europeanwide coordination is emphasized with European Networks
playing a key role in the development of preparedness planning to mitigate the impact of such mass emergencies. Now,
in 2016, the official Communique of the Nuclear Security
Summit 2016, held in Washington, testifies: ‘The threat of
nuclear and radiological terrorism remains one of the greatest challenges to international security, and the threat is constantly evolving’ (Nuclear Security Summit 2016, Washington,
Communique April 14, http://www.nss2016.org/).
It can be expected that malevolent attacks will occur without any advance warning and will target as many people as
possible in order to cause maximum damage. Following such
a scenario, the classification (or sorting) of persons according
to their degree of injury (no need for immediate medical
care/need for immediate medical care/medical help impossible) and exposure will be one of the initial steps for emergency management. While the triage of individuals will be
done by physicians based on clinical signs and symptoms in
the first instance, biodosimetry can support subsequent medical management by providing information about individually
received doses to blood or to components of personal devices, such as smart phones or mobile phones.
The situation during large-scale accidents may differ from
malevolent attacks, as often advanced warning of an event
allows to distribute personal dosimeters and install local dosimeters for precise dose surveillance within the disaster area
and close monitoring of the distribution of released radionuclides. However, even in such cases, the identification and
assurance of the huge number of ‘worried well’ individuals,
i.e. persons who are extremely distressed but have not actually received radiation doses likely to cause acute health
effects, will be most important in order to prevent the
healthcare infrastructure being overwhelmed and to avoid
socioeconomic harm. Also in restricted accidents with an
assumed smaller group of victims, the numbers of distressed
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persons can be enormous, as already was shown in the
Goiania accident in 1987. This very severe radiological accident resulted in the death of four individuals due to overexposure and internal contamination (International Atomic
Energy Agency [IAEA] 1988) (http://www-pub.iaea.org/mtcd/
publications/pdf/pub815_web.pdf). Additionally, 249 persons
were identified as contaminated with radioactive caesium,
however, in 120 cases only the clothing was contaminated
but a total of 112,800 persons felt affected and needed to be
monitored for contamination. In this context, it was also
shown that anticipatory stress associated with a potential
exposure to ionizing radiation resulted in a level of stress
similar to that from actual exposure to ionizing radiation
(Collins & de Carvalho 1993). Based on the expertise from the
Goiania accident, the following recommendation was given
by the IAEA: ‘ … cytogenetic dosimetry is an extremely useful
technique for estimating the external whole body radiation
dose and the inhomogeneity of dose of the irradiated person. It is helpful in providing useful information to the physician responsible for diagnosis and prognosis. It is suggested
that national authorities review their emergency plans to
ensure that laboratories capable of carrying out this work are
available, either internally or by international cooperative
arrangements. Intercomparison programmes should be carried out to establish a desirable level of coherence among
the different laboratories’ (IAEA 1988).
Biological dosimetry and EPR/OSL dosimetry was also
conducted after the Chernobyl accident, e.g. for inhabitants
and visitors of contaminated sites, evacuees and liquidators
(Stephan & Oestreicher 1989; Silini & Gouskova 1991;
Verschaeve et al. 1993; European Commission [EC] 1996;
Maznik et al. 1997) and also for people living in European
areas with comparably high fallout measurements due to
contaminated rain (Stephan & Oestreicher 1993). Following
the Fukushima Daiichi nuclear power station accident, biodosimetry was performed for restoration workers (Suto et al.
2013) and also for individuals who travelled to contaminated areas after the accident (Lee et al. 2012). However, in
all these studies biodosimetry was performed by single laboratories and the number of examined persons was rather
limited.
In each context, biological dosimetry (based on, e.g. cytogenetic assays) and retrospective physical dosimetry (based
on EPR/OSL techniques) has been shown to be an essential
tool to estimate the individually received (blood or personal
device) dose without being influenced by temporal variations
in blood counts or confounding factors such as chemical
agents or psychogenic reactions. Based on the results of biological and personalized physical dose estimation, people
needing extensive medical care due to severe irradiation can
be identified and distinguished from individuals with injuries
who have not received high doses of ionizing radiation (Turai
et al. 2001; Voisin et al. 2001; Roy et al. 2007; Romm et al.
2011; Jaworska et al. 2015). In those disastrous situations,
independently of an accidental or malevolent background,
the reassurance of unsettled and anxious people is of high
importance. It was shown repeatedly that psychological consequences of radiological disasters are basically connected to
a perceived exposure, that in most cases clearly differ from a
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calculated dose, based on measurements of the environment
(Collins & de Carvalho 1993; Bromet et al. 2011; Bromet
2012). The success to reassure people to readopt a normal
life will, to a great part, depend on the credibility of the
authorities. To address people on a personal level by offering
individualized dose estimation can clearly help to minimize
psychological stress and regain trust, even if such an
approach, on a large scale, will take time (over months) and
probably will have to be performed based on a priority
action plan. However, according to practical experiences of
experts working in biodosimetry laboratories and involved in
several small accidents, anxiety and fear very often do not
necessarily start immediately after an assumed incident but
also weeks or even months later. Thus, in the long run, biological dosimetry and personalized dosimetry will help to
reduce socioeconomic harm in the affected country.
In a large-scale radiological accident or terrorist incident,
the number of people that may need to be screened could
easily exceed the capacity of a single or even a number of
laboratories. As a consequence, biodosimetry networking has
been recognized as a sensible and important emergency
response strategy in several regions of the world (Turai 2000;
Wilkins et al. 2008, 2011). Under the patronage of the IAEA, a
regional network of six laboratories has been set up, that
covers the whole of Latin America. At national levels, a similar initiative has been promoted in the USA by the US
Government and networks have also been established in
Japan and Canada (Mitsuaki et al. 2007; Miller et al. 2007),
while in Europe, a tri-partite memorandum-of-understanding
for mutual assistance between France, Germany and the
United Kingdom became effective in 2004. However, this
European agreement applied only for serious radiological
events in these three countries and, with only one laboratory
per country, the total capacity was also extremely limited. On
a global level, the World Health Organization (WHO)
BioDoseNet was set up (Blakely et al. 2009) and IAEA also
includes biodosimetry laboratories in its Response and
Assistance Network (RANET) (IAEA 2013). Currently, the best
methods of biological dosimetry are based on the analysis of
chromosomal damage (dicentric chromosomes, micronuclei
and translocations) in peripheral blood lymphocytes and
electron paramagnetic resonance in bone and tooth enamel
(Lloyd et al. 2000; IAEA 2002, 2011; Blakely et al. 2005;
Fattibene & Wojcik 2009; Romm et al. 2009; Willems et al.
2010; Ainsbury et al. 2011; Beinke et al. 2013; Wojcik et al.
2014). These methods have been validated in a number of
small-scale radiation accidents and have been shown to be
reliable tools to detect an absorbed individual blood dose of
radiation with enough accuracy. During the last years, more
biodosimetric methods have been identified and used, such
as premature chromosome condensation (PCC), fluorescence
in situ hybridization (FISH) and gamma-H2AX foci (Terzoudi &
Pantelias 1997; Fattibene & Wojcik 2009; Horn et al. 2011). In
addition, the electron paramagnetic resonance (EPR) and
optically stimulated luminescence (OSL) on personal objects
(portable electronic devices, chip cards), although not a typical biodosimetric method, has been shown to have the
potential to be an excellent supplement especially if irradiation is heterogeneous (Woda et al. 2009; Trompier et al.

2010). As has been shown in the TENEB (Towards a European
Network of Excellence in Biological Dosimetry) project, one
or more of these methods are established in many European
laboratories (Wojcik et al. 2010). However, networking for
these techniques, which would consolidate the standardization and harmonization of the assays, was lacking. In 2009,
all existing European laboratories with considerable experience in biological dosimetry were identified and listed with
the help of the TENEB survey (www.andrzej.se/teneb/). Many
of these laboratories had expressed their interest in a longterm commitment to contribute to a European biodosimetry
network. These laboratories formed the nucleus for the
RENEB (Realizing the European Network of Biological
Dosimetry) project.
The purpose of RENEB was to use the existing knowledge
and laboratory capacities, available in European countries to
set up a European network of biodosimetry.
In 2012, a total of 23 organizations from 16 European
countries joined forces and started to realize this project, in
order to guarantee the highest efficiency in processing and
scoring of biological and personalized inert samples for fast
and reliable dose estimations on an individual level to support EU emergency management (Kulka et al. 2012).

Results
RENEB project partners (‘starting members’)
The basis for the identification of appropriate network partners was the TENEB survey (www.andrzej.se/teneb/) (Wojcik
et al. 2010), listing all existing European laboratories with
considerable experience in biological dosimetry. Many of
these organizations had expressed their interest in a longterm commitment to contributing to a European biodosimetry network. Additional partners joined from the EU project
‘MULTIBIODOSE’ (http://www.multibiodose.eu) and/or were
members of Working Group 10 ‘retrospective dosimetry’ of
the EURADOS association (www.eurados.org), and thus have
experience in the development and application of biodosimetric tools. In total, 23 organizations from 16 European
countries built the RENEB consortium at the start of the project in 2012 (Kulka et al. 2012; Voisin et al. 2012). Members
comprised Civilian and Military Research Institutes, Civilian
and Military Hospitals, National Health Institutes, National
Research Institutes, National Radiation Protection Authorities
and Universities (Table 1). Most of the partners had research
experience but also practical experience in handling radiation
accidents, and a number of them had specially defined missions to undertake national tasks linked to radiation protection and biological dosimetry with the status of an official
national biodosimetry laboratory. Due to the direct links to
many national authorities and the high number of partners
who had signed the long-term commitment, it was hoped
that the project would result in an operational, legally
defined Biodosimetry network. Other partners, mainly from
research centres and universities, brought in academic knowledge and practical experience with emerging technologies
showing promise for application in biological dosimetry, and
thus provide further support for the sustainability of the
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Table 1. RENEB consortium partners and their contribution to the network in
2012.
Participant

Country

1 BfS
2 BIR/UULM
3 CEA
4 ENEA
5 HMGU
6 HPA
7 ICHTJ
8 INSP
9 IRSN
10 ISS
11 ITN
12 LAFE
13 LUMC
14 NCRRP
15 NCSRD
16 NRIRR
17 NRPA
18 STUK
19 SU
20 UAB
21 UGent
22 UNITUS
23 SERMAS

Germany
Germany
France
Italy
Germany
United Kingdom
Poland
Romania
France
Italy
Portugal
Spain
The Netherlands
Bulgaria
Greece
Hungary
Norway
Finland
Sweden
Spain
Belgium
Italy
Spain

Assaysa
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e






Contact
labb Commitmentc Involvementd
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Operational basis
An ‘Operational Network Basis’ was set up with five biodosimetric tools, the dicentric assay (DCA), the FISH assay (FISH),
the micronucleus assay (MN), the premature condensed
chromosome assay (PCC) and the gamma-H2AX assay. In
addition, the retrospective physical dosimetric tools electron
paramagnetic resonance (EPR) and optically stimulated luminescence (OSL) were included. While one or more of these
methods were already established and used for individual
dose estimation in many European laboratories, standardization and harmonization was needed to consolidate the techniques for networking.











a

Assays for biological or retrospective physical dosimetry; bNational biological
or physical dosimetry lab or link to national/regional lab; cLong-term commitment to contribute to biological dosimetry; dInvolvement in complementary
projects, associations or networks; enot actively involved in RENEB after 2014.

network. It should also be stressed that several partners are
actively involved in quality assurance activities such as developing standards for biological and physical-retrospective dosimetry for the International Organization for Standardization
(ISO) (Voisin et al. 2002; Roy et al. 2012; ISO 19238 2004; ISO
21243 2008; ISO 13304 2013; ISO 17099 2014) and this
ensures high quality standards and quality management
within the network. Three of the partners (BfS, IRSN, HPA)
had experience in networking within the tri-partite memorandum of understanding for mutual assistance in case of a serious radiological event (but restricted to the related
countries) and several of the 23 partners were involved in
the biological network of the WHO, BioDoseNet (Blakely et al.
2009). Additionally, many of the laboratories were involved in
education and training activities, such as intercomparisons,
laboratory staff training or exchange initiatives. The RENEB
consortium partners in 2012 and their contribution to the
network are shown in Table 1.
Despite signing a long-term commitment within the frame
of the TENEB project, some organizations decided to withdraw from this obligation, closed their laboratories (LUMC,
STUK) and finalized their active involvement in networking.
At the end of the project (December 2015), 21 from originally
23 partners from 14 European countries were involved in the
project.

Operational network set-up
The operational set-up is based on three main pillars, (1) the
operational basis, (2) the basis for education, training and
quality assurance, and (3) the basis for network development.
All three components are closely connected and act in a
coordinated way (Kulka et al. 2015).

Intercomparisons
The specific needs and potential for improvement for both
techniques and partners were principally identified by two
intercomparison exercises. While the first of the exercises was
restricted to the network partners, the second intercomparison was open also for potential new members and with
regard to the dicentric assay and micronucleus assay also for
networks outside Europe. Details and outcome of the intercomparisons are shown in independent articles, included in
this special issue, for the dicentric assay (Oestreicher et al.
2016), the FISH assay (Barquinero et al. 2016), the micronucleus assay (Depuydt et al. 2016), PCC assay (Terzoudi et al.
2016), the gamma H2AX assay (Barnard et al. 2014; Moquet
et al. 2016), and for physical dosimetry methods (Trompier
et al. 2016b), as well as in Fattibene et al. (2014) and
Bassinet et al. (2014).
Besides the identification of needs for harmonization and
standardization, valuable information about shipment of samples was provided by the intercomparisons. This included
information about shipment time, temperature gradient of
the samples during the shipment, a possible additional dose
received during the shipment and other, non-foreseeable
incidents. Details about the shipment within and outside the
EU are also given in the dicentric report, included in this special issue (Oestreicher et al. 2016).
Accident simulation exercise
In addition to the intercomparisons, a virtual two-part accident simulation exercise was performed over a period of 27
weeks. In contrast to the intercomparisons, this exercise was
not split by assay. Instead, each participant had to evaluate
the dosimetric readings derived from every tool in an
attempt to gain knowledge about the possibilities and limitations of each tool and learn how the results should be interpreted. The main aims of the exercise were, however, to test
the network activation procedure by allowing each partner
to send an alerting e-mail about a fake radiation emergency,
and to collect the responses about the availability of all the
partners and their current capacity to handle samples. After
responding to the alerting e-mail, the second part of this
exercise comprised receipt of a panel of arranged irradiation
doses for each of several potential victims. Partners had to
classify these persons correctly according to criteria that
included information about the individual dose estimates
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Table 2. RENEB key information about the operational network performance.
Classification of individuals: Green/
Orange/Red (<1 Gy/1–2 Gy/>2 Gy)
Time frame
for sample
collectiona

Time from
sample receipt
to resultb
52 hours
75 hours
120 hours
2–8 hours

Assay

Sample
type

Dic
MN
FISH
PCC

blood
blood
blood
blood

days - months
days - months
days - years
hours - months

cH2AX

blood

days

EPR
OSL

PEDf
PEDg

hours - years
hours - months

RENEB capacity
(analyzed persons
per week)
ca.
ca.
ca.
ca.

1000
400
100
50

3 hours

ca. 1800

<1 hour
<1 hour

ca. 770
ca. 500

Robustnessc

Implication of
individual
sensitivityd

Stored material: Type and
time range for further
analysise

0.1–5
0.2–5
0.3–4
0.1–20

high
medium
medium-high
high

yes
yes
yes
yes

0.2–5

low

?

high
high

no
no

fixed cells, slides: years
slides: years
fixed cells: years
frozen lympho-cytes, fixed
cells, slides: years
fixed cells, slides: up to
one year
glass: years
resistors: weeks

Detection
range (Gy)

>1
>0.1

a
Time between irradiation and sample collection; bTime from arrival of a sample in the laboratory until the classification of a person, without time for transport/
shipment; cRobustness: high, little influence of disturbing factors; medium, some influence of age, smoking, other agents; low: large influence of other agents
and factors; dConsidering the individual sensitivity of a person; eType of the stored material and time frame to perform further analysis; fPED, personal electronic
device (glass touchscreen, e.g. smart phone); gPED, personal electronic device (resistors from circuit board, e.g. mobile or smart phone).

from different assays and allowed for discrimination between
whole body and partial body exposure and the time of the
irradiation. The partners were trained in handling large data
sets; in addition, the repeated collection of information gave
an important insight about the capacity of each lab to the
state of preparedness of the network. Details and outcome
of this accident simulation exercise are described in this special issue (Brzozowska et al. 2016). Key information about the
operational network performance is given in Table 2, based
on the findings of the accident simulation exercise
(Brzozowska et al. 2016) and on a survey amongst RENEB
partners (Monteiro Gil et al. 2016).
Full information about the activities of the operational
basis are given in the article by Wojcik et al. (2016).

Education, training and quality assurance
In the event of an accident involving a large number of
potentially irradiated people, the response kinetics of the
network depend tightly on the efficiency of all labs involved
in the response, not only individually but also in coordination. The best operational conditions will result from ensuring the preparedness of the network in advance of any
event. Such provision includes homogenization of procedures
within the individual laboratories, maintenance of qualified
staff, knowledge of the laboratory capacity in crisis situations
and common training through implementation of periodic
exercises and intercomparisons.
Therefore, the basis for ‘education, training and quality’ is
a significant component of RENEB, and has large influence
on the performance of the whole network. This includes the
‘Operational Basis’ dealing with established biodosimetry
assays, and the ‘Basis for Network Development’, providing
the basic principles to include new methodologies and new
partners. The applied quality standards conform with international standards including ISO 19238: Radiation Protection
– Performance criteria for Service Laboratories performing
Biological Dosimetry by Cytogenetics (ISO 19238, 2004), ISO
21243: Radiation protection – Performance criteria for laboratories performing cytogenetic triage for assessment of
mass casualties in radiological or nuclear emergencies –
General principles and application to dicentric assay (ISO

21243, 2008) and ISO 17099: Radiation Protection –
Performance criteria for laboratories using the cytokinesis
block micronucleus (CBMN) assay in peripheral blood lymphocytes for biological dosimetry (ISO 17099, 2014). In this
regard, RENEB takes advantage of the fact that several partners are actively involved in global quality assurance and in
the development of the ISO standards for biological dosimetry (Voisin et al. 2002).
Within the network, measures have been determined and
actions implemented to promote a comparable high performance of the partners and quality assured integration of
potential new members. The actions comprise practical training, seminars, and training cooperation with existing nuclear
safety/radioprotection programmes or with European radiation protection platforms.

Training activities
Practical training events concerning quality and efficiency of
the performance were carried out to correct individual shortcomings and networking problems. According to the particular needs of each partner, the training was organized by
RENEB partners with appropriate expertise. In addition, training was also organized for partners who wished to widen
their laboratory assay spectrum by including another assay
into their own operational toolkit.
In addition to the practical training, seminars on statistics,
international
standards
of
the
Organization
for
Standardization (ISO standards) and quality assurance and
quality management (QA&QM) were given. The seminars on
statistics, quality and metrology and theoretical lessons were
run in parallel with applied table-top exercises. The course
topics addressed basic statistical aspects related to the establishment of dose-effect calibration curves and to individual
blood dose estimation, the need of a quality system for the
traceability and management of particular activities, and
especially practical metrology aspects. In another seminar
focussing on methodology of the various techniques, a common QA&QM manual was discussed in order to identify and
fix the specific QA&QM criteria for each assay.
The QA&QM programme was jointly developed by the
consortium with the purpose to define the use of the
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different biological and/or biophysical assays as elements of
the operational basis of the RENEB network. While parts of
the information from this document are contained in other
international guidelines and scientific publications, e.g. IAEA
Technical Reports Series on Biological Dosimetry, the RENEB
document covers the full range of the assays that are
included in the network. As such, the document is of primary
importance for sustaining the credibility of the network partners and the readiness of the network to respond to requests
from first responders, national and European authorities and
Research and Development (R&D) agencies.
A long-term training programme was developed to
ensure adequate organization of training for members for
dose assessment in large-scale accidents and to integrate
new partners in a quality assured manner. The training
programme includes periodic intercomparisons that are
mandatory for RENEB partners, but will be open for nonpartners as well. Successful performance of the laboratory
will qualify the partner to be included in dose reconstruction in real emergency situations and to participate in R&D
projects.
Besides the RENEB-internal activities, training cooperation
with European nuclear safety/radioprotection courses and/or
European radiation protection platforms have been initiated.
Informal contacts have been taken with some training structures in Europe (e.g. ENSTTI in France) and European programmes developing strong action in this field (e.g. MELODI
and CONCERT-European Joint Programming). The seminar on
statistics, ISO standards and QA&QM was given in cooperation with ENSTTI and a course focussing on cytogenetic
assays and EPR/OSL for individualized dose estimation has
been jointly developed by RENEB and EURADOS and will be
open to interested scientists.
A virtual crises exercise that was complementary to the
previous accident simulation exercise within the operational
basis of the network was performed. The purpose of the
exercise was to test the link between the national authority
and the RENEB member(s), who act as national reference
laboratory(s).

New member qualification
A decision table for providing information to the network on
the competence level of the candidate partners and to
inform these potential partners on the minimum requirement
to join the network was developed and is distributed to laboratories and institutions who express an interest in becoming
a network member. Additionally, a questionnaire to evaluate
the technical and operational capacity of the new members
has been created in order to ensure network information is
current and up to date.
More considerations and findings with impact on Quality
Assurance concern the impact of uncertainty on triage category (Ainsbury et al. 2016a), and lessons learned by the
intercomparisons as described in the article by Trompier
et al. (2016a).
All details about these activities in education, training and
quality assurance are provided in the.+ article by Gregoire
et al. (2016).
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Network development
The established network was never designed to be a static or
closed consortium, the sustainability will rather depend on
openness and the ability to react in a flexible way towards
new situations. This implies the awareness of new technological developments as well as dealing with the loss and
gain of network members. It was a major goal of the RENEB
consortium to actively identify potential new partners
(‘candidate partners’) and promising techniques (‘candidate
techniques’) already during the installation of the network. In
this regard, a strategy was prepared to actively identify,
evaluate and if appropriate integrate new partners and new
techniques with potential for biodosimetry in RENEB. The
recruiting strategy resulted in the application of eight new
laboratories who became RENEB candidates and several new
methods, including -omics technology and molecular-biological approaches, as well as some further developments of
established techniques that became candidate methods. The
spectrum of new techniques and the performance of new
partners were evaluated, and integration steps were developed and implemented in close collaboration with Education
and Training (E&T) activities.
Identification, testing and validation of new technologies
A four-point strategy was designed and applied to attract
new ‘candidate’ techniques in biodosimetry. The strategy
includes: (1) to attract people to RENEB and make them
reporting new techniques, e.g. at scientific meetings, (2) to
attract new techniques through the RENEB website including
a ‘Reporting sheet for new techniques’ for a first contact, (3)
direct request to RENEB members to suggest new technologies, and (4) literature search for new technologies in biodosimetry. At the beginning, a direct contact to scientists
working with a promising technique was most successful.
However, with the increasing awareness of the network and
degree of familiarity, people used the reporting sheets to
introduce particular techniques or improvements. For the
evaluation and integration of potential new technologies in
the network, a roadmap was elaborated. The workflow
includes (1) official reporting of a suggested new method, or
extensive further development of an existing technique for
biodosimetry within RENEB through the reporting sheet,
(2) evaluation of the suggested methods in close
cooperation with the operational basis and basis for E&T and
QA under consideration of fixed criteria, (3) invitation of candidate techniques to participate in intercomparisons, and (4)
decision of the network about the integration based on the
performance
The developed tools were applied to identify some promising techniques during the last 4 years and several candidate methods were suggested to the RENEB consortium and
presented at the annual RENEB meetings. The methods
included different types of the gene expression assay (qPCR,
array based technology), thermoluminescence of mobile
phone display glass, Raman spectroscopy and further developments of established methods as dicentric and PCC assay
by combining them with centromere and telomere staining
(M’kacher et al. 2014, 2015; Karachristou et al. 2015; Abend
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et al. 2016). Some of these methods were included in RENEB
intercomparisons and results are published in this special
issue (Manning et al. 2016).
In December 2015, an additional intercomparison of new
methods for biodosimetry was performed, in which the performance of established assays already included in RENEB
and candidate methods was directly compared. The outcome
of this exercise is published in this special issue under the
title ‘Validation and testing of new RENEB retrospective dosimetry techniques’ (Ainsbury et al. 2016b).

Identification, evaluation and integration of new network
partners
To attract candidate partners to RENEB a five-point strategy
was developed: (1) to attract people to RENEB and encourage them to report their laboratory’s capabilities, e.g. at scientific meetings or meetings related to emergency
preparedness (e.g. from IAEA, WHO), (2) to attract new partners through the RENEB website including a ‘Reporting
sheet for new members’, (3) suggestion of new partners by
third parties, (4) to contact appropriate laboratories by
national health authorities from EU countries using an information letter (developed for this occasion), and (5) to screen
current publications for possible candidates. Again, the direct contact to scientists and presentations about RENEB at
meetings proved to be the most effective way to attract
individuals and laboratories.
In cooperation with the basis for Education, Training and
Quality, formal criteria for the integration of candidate partners were elaborated. The main criteria are: (1) description of
the biodosimetric methods used, (2) quality assurance and
quality control procedures applied in the laboratory, (3) information about assay capacities (samples per week), (4) information about sample processing time (days to result), (5)
participation and performance in intercomparisons, and (6)
information about the staff levels.
At the end of 2015, eight candidate members showing a
serious interest to join the RENEB network were identified
and these groups have started the integration process. An
overview of these candidate members is given in Table 3.
In summary, RENEB has proved to be a dynamic and open
network. The campaign to scout for new partners was effective with eight laboratories showing an interest to actively
participate once the network is established. All eight candidates participated in RENEB exercises (2nd laboratory intercomparison and accident simulation exercise) and presented
their institutions to the RENEB consortium at one of the
annual meetings.

Sustainability of the network
Integration in European and international radiation
emergency and preparedness
First and foremost, RENEB was established to contribute to
radiological emergency preparedness and response. Since the
start in 2012, the network has been accepted as a partner by
international emergency and preparedness organizations
such as WHO and IAEA. Representatives of RENEB contributed to WHO Radiation Emergency Medical Preparedness
and Assistance Network (REMPAN) (14th WHO REMPAN meet€rzburg, Germany, 2014) and WHO BioDoseNet
ing, Wu
Coordination meetings (Leiden, the Netherlands, 2013;
Hanover, NH, 2015), as well as to meetings of IAEA addressing biological dosimetry [First research Coordination Meeting
(RCM) of the IAEA-CRP on ‘Strengthening of Biological
Dosimetry in IAEA Member States: Improvement of current
techniques and intensification of collaboration and networking among the different institutes’, Vienna, Austria, 2012;
IAEA/NIRS Technical Meeting ‘Future of Biodosimetry in Asia:
Promoting a regional Network’, Chiba, Japan, 2015]. Both
institutions were directly involved in the set-up of the network by acting as members of the RENEB Advisory Board.
This cooperation is intended to be continued, conceivably in
form of RENEB honorary members. For the international perception of the network in emergency preparedness and
response, the 2nd RENEB intercomparison was of utmost
importance. The joint exercise with biodosimetry partners
from Latin America, North America, Asia, Africa and the
involvement of laboratories from the WHO BioDoseNet and
IAEA RANET strengthened the acceptance of the European
network as a partner in the global Emergency and
Preparedness Response. It also demonstrated that networking
in biodosimetry is possible on a global level and a valuable,
ready-for-service tool for emergency preparedness and
response.
Integration in European radiation research initiatives
Beside the usefulness of the network for emergency
response, it is obvious that the capacities of the RENEB network laboratories, the harmonization of methodologies in
these laboratories and the technological advancements can
serve as a resource for large research projects as well.
Therefore, in order to guarantee a long-term sustainability of
RENEB, joint research interests within the network partners
and in particular with EU radiation research programmes
were identified and the benefits of RENEB for European radiation research were outlined. At the beginning of 2016, the

Table 3. RENEB candidate members as of December 2015.
Organization

Acronym

Country

Background

Belgian Nuclear Research Centre
Laboratori Nazionali di Legnano
Army Medical & Veterinary Research Centre
Forschungszentrum J€
ulich
University of Sevilla
Dublin Institute of Technology
Radiation Protection Centre
French Army Biomedical Research Institute

SCKCEN
INFN
AMVRC
FZ J€ulich
US
DIT
RPC
IRBA

Belgium
Italy
Italy
Germany
Spain
Ireland
Lithuania
France

Research Centre
Research Centre
Army Medical and Veterinary Research Centre
Research Centre
University
Institute of Technology
Radiation Protection Centre
Army Biomedical Research Institute
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RENEB network is well known by the radiation research community in Europe and beyond. Close links to the European
Radiation Protection platforms EURADOS (http://www.eura€hm et al. 2014,
dos.org), focussing on dosimetric aspects (Ru
2016), MELODI (http://www.melodi-online.eu), focussing on
low dose effects (Salomaa et al. 2013), NERIS (http://www.euneris.net), focussing on emergency preparedness, and
ALLIANCE (http://www.er-alliance.eu), focussing on radioecological aspects, have been developed and the integration status of the RENEB network in the European Radiation
Research Area has been shown to be excellent. The next
steps are already initiated to integrate RENEB in CONCERT –
the European Joint Programme (EJP) for the Integration of
Radiation Protection Research, here, RENEB is presented as
an ‘analytical platform for emergency and scientific research’.
Of major importance for the EJP are the Strategic Research
Agendas (SRA) of the radiation research platforms, as this is
the basic instrument to identify research needs and to determine priorities that should be stimulated and supported by
European and national programmes. In this regard, it is
encouraging that the topic ‘biodosimetry’ is addressed in the
SRA of MELODI (http://www.melodi-online.eu/sra.html) and
EURADOS
(http://www.eurados.org/en/news/eurados_strategic_research_agenda). Both platforms have explicitly
included the network in their SRA, as an infrastructure for
retrospective dose assessment in research studies and for
emergency preparedness.

RENEB SRA
As RENEB developed, an own SRA became more and more
important. A draft Strategic Research Agenda for RENEB
2016þ was developed and priorities were identified regarding how to proceed after the end of the funded period of
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the project. The SRA addresses (1) information about the
partner organizations and applied assays, (2) the different
tools for dose assessment, included in the network and their
specific field of application, (3) the benefit of RENEB outputs
for emergency preparedness and response as well as for radiation research, with special focus on Education & Training
and Quality Assurance & Management, (4) a vision at 2030
‘Towards a better individual dose estimation’, (5) a strategy
for how to meet this vision, (6) aspects of sustainability and
conclusions, and (7) priority stetting for the next steps.
Development of the SRA was a major step towards supporting the long-term sustainability of the network and to facilitate the integration process of RENEB within the European
radiation research community. It is intended that the SRA will
always have the status of a ‘draft document’ and will be further developed on a regular basis.

RENEB Memorandum of Understanding
Various legal options for the formal structure of the future
network have been compiled. A legally non-binding agreement in the form of a Memorandum of Understanding
(MoU), signed by as many partners and candidates as possible, was identified to be the most appropriate way to start
the transformation of the time-limited project into a formal
structure of a sustainable network. A MoU, based on the
existing tripartite network of France, Germany and the UK,
was expanded and adapted to the needs of the RENEB network. The aim was provision of assistance to all EU states,
including those without a national capability. In January
2016, from 30 organizations formally participating in RENEB,
a total of 26 have signed the MoU, as shown in Table 4. The
MoU thus forms the nucleus of a growing infrastructure,
combining high quality standards in the application and

Table 4. RENEB partners with a signed Memorandum of Understanding (MoU) as of January 2016.
Acronym

OMa/CMb

BfS
CEA
ENEA
ICHTJ
INSP
IRSN
ISS
IST
LAFE
NCRRP
NCSRD
NRPA
OSSKI
PHE
SERMAS
SU
UAB
Uni Gent
UNITUS
FZ
INFN
AMVRC
SCK-CEN
RSC
DIT
US

OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
OM
CM
CM
CM
CM
CM
CM
CM

a

Organization

Country

Bundesamt f€
ur Strahlenschutz
Commissariat a l’Energie Atomique et aux Energies Alternatives
Agenzia Nazionale per le Nuove Tecnologie, LEnergia e lo Sviluppo Economico Sostenibile
Institut Chemii i Techniki Jadrowej
Institutul National de Sanatate Publica
Institut de Radioprotection et de S^urete Nucleaire
Istituto di Superiore di Sanita
Campus Tecnologico e Nuclear, Instituto Superior Tecnico, Universidade de Lisboa
Fundacion para la Investigation del Hospital Universitario la Fe de la Comunidad Valenciana
National Center for Radiobiology and Radiation Protection
National Centre for Scientific Research Demokritos
Norwegian Radiation Protection Authority
National Public Health Centre - National Research Directorate for Radiobiology and Radiohygiene
Public Health England
~o de Salud - Hospital General Universitario Gregorio Maran
~on
Servicio Madrilen
Stockholm University
Universitat Autonoma de Barcelona
Universiteit Gent
University of Tuscia
Forschungszentrum J€ulich
Laboratori Nazionali di Legnaro
Army Medical and Veterinary Research Center
Belgian Nuclear Research Center
Radiation Protection Center
Dublin Institute of Technology
University of Sevilla

Germany
France
Italy
Poland
Romania
France
Italy
Portugal
Spain
Bulgaria
Greece
Norway
Hungary
United Kingdom
Spain
Sweden
Spain
Belgium
Italy
Germany
Italy
Italy
Belgium
Lithuania
Ireland
Spain

Original member; bformer Candidate member.
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validation of biomarkers and maintenance and further development of scientific and technical competence.
An important aspect of preparedness for mass casualty
radiological/nuclear events at a national or international scale
is the need for functional efficiency of the biodosimetry network. Besides an appropriate network structure and a legal
basis, well-established communication channels and logistic
procedures to handle hundreds or more samples in an efficient and timely manner had to be identified and assured to
be able to provide mutual assistance between many biodosimetry laboratories.

Funding strategies
Financial issues and funding mechanisms are of utmost
importance for the sustainability of the RENEB network. In
the current European organizational framework, the creation
of technology platforms and networks of institutions (laboratories, research centres, universities, national public bodies
and in some cases companies) is encouraged by the
European Commission and, in the initial phase, funded to
some extend (such as RENEB) in order to develop structure
and to aggregate the relevant institutions and experts.
However, in the medium- and long-term, such platforms and
networks must be self-sustainable, i.e. must not depend on
funding from the European Commission. For a future operational and scientific platform, there are different options for
funding sources. The following additional funding options
have been identified by the consortium for further consideration: (1) membership fees, (2) intercomparison exercises, (3)
workshops & training courses, (4) annual meetings with a
registration fee, (5) partner in calls of EJP CONCERT and (6)
partner in other HORIZON 2020 calls (EURATOM, SECURITY,
etc.).
Dissemination activities
The awareness level of the network and broad knowledge
about its activities and capability is essential for the longterm-sustainability of RENEB. Therefore, efforts were focused
on dissemination activities to enhance the visibility of RENEB
on national, European and global levels.
In order to promote RENEB, the consortium created a public web page (www.reneb.eu) and published three bulletins,
presenting the RENEB network and progress of the work. The
bulletins are available on RENEB external web page under
‘Publications’ chapter (http://reneb.eu/publications.html) and
are distributed as paper copies, e.g. at international radiation
emergency response and radiation protection meetings.
Up to now, consortium partners published 24 peerreviewed, scientific papers with reference to the RENEB project with this special issue ‘Networking in biological and EPR/
OSL dosimetry: the European RENEB platform for emergency
preparedness and research’ highlighting the most recent successes. This is remarkable for a project that was not set up to
perform research but to establish a network. RENEB has been
presented at national and international meetings focussing
on radiological emergency preparedness, and on research
with more than 60 talks and 30 posters.

There were also numerous additional dissemination activities including the organization of seminars on statistics and
QA&QM, open sessions accompanying the annual RENEB
meetings in 2014 at the Hospital La Fe in Valencia, Spain,
including a press conference, and in 2015 at ENEA in Rome
and at the EPRBioDose meeting in Hanover, NH. A particular
dissemination event ‘Nuclear and Radiological Accidents –
Establishing a European Network of Biodosimetry’, on 26
November 2015 was held at the European Commission in
Brussels and people involved in emergency preparedness
and response and in radiation research were invited to learn
about the capabilities of the network (http://reneb.eu/
Dissemination_event_in_Brussels).

Conclusion and future prospects
The EU project ‘RENEB – Realizing the European Network of
Biodosimetry’ has coordinated the consolidation of European
laboratories that are experienced in biological and physical
retrospective dose estimation with the objective of initiating
a European Biodosimetry network. At the end of the project
2015, a biodosimetry network with a legal structure is established under the same acronym but slightly adapted name
‘RENEB – Running the European Network of biological dosimetry and physical retrospective dosimetry’. At the beginning
of 2016, 26 member organizations form the nucleus of a
unique growing infrastructure, combining high quality standards in the application and validation of biomarkers and
maintenance and further development of scientific and technical competence (Comments from the Advisory Board,
Lisbon, December 2015: http://reneb.eu/news.htm; Lloyd
et al. 2016) (Figure 1)
The major impact of RENEB is a significant improvement
of citizens’ reassurance through an improved emergency preparedness system, respecting the need for dose estimation
on an individual level. RENEB will be activated after a radiological emergency to provide fast, professional support to
first responders to deal with exposed and potentially
exposed people. This activity will reduce the health consequences of a radiation emergency, in terms of both the physical and mental aspects. To address people on a personal
level by offering individualized dose estimation thus will help
to minimize psychological stress and to regain trust in
authorities.
More specifically, the impacts of RENEB can be described
as (1) Emergency preparedness and management systems
contributing to socioeconomic impact and wider societal
implications, (2) high quality research standards, (3) maintenance of infrastructure in the field of biological and retrospective physical dosimetry, (4) maintenance of knowledge
in the field of biological and retrospective physical dosimetry, and (5) development of a model for long-term sustainability of biological dosimetry. Several of these topics can
significantly contribute to EURADOS’ vision for dosimetry of
ionizing radiation such as ‘Improved radiation risk estimation deduced from epidemiological cohorts’ or ‘Efficient
dose assessment for radiological emergencies’ (R€
uhm et al.
2016).
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Network for
biological and retrospective physical dosimetry

Link to
national and international
emergency preparedness and
response organisations

Analysis Capacity:
Operational Basis

Quality Assurance:
Education & Training
Quality Management

Link to
European and international
radiation research
orgnisations and platforms

Network Development:
biomarkers of exposure
& new members

for emergency preparedness
and
radiation research

Figure 1. Activities and crosslinking of the RENEB network.

RENEB has resulted in the EU-wide preparedness for fast
and reliable biological as well as EPR/OSL dose assessment
following a radiological accident or terrorist attack involving
a potentially large number of affected individuals (Table 2).
With the help of this network implemented within/in parallel
to existing emergency preparedness systems (Carr 2010, IAEA
2013, Rojas-Palma et al. 2009), it will be possible to significantly assist the emergency management by supporting
medical decisions, estimating the stochastic radiation damage and also by identifying false positive exposure and thus
reassuring the worried well. This especially will reduce socioeconomic harm, as following an emergency, the fears and
anxiety of people need to be respected and considered on
an individual level.
A major requirement of cooperation in biodosimetry is the
exceptionally high level of standardization and harmonization
of the tools to achieve reliable and comparable dose estimates. This demands high-level education and training activities as well as accurate and attentive quality assurance and
quality management. The high degree of the RENEB quality
assurance and quality management will thus improve the
research activities of each single laboratory involved in the
training programme. It will also be available for interested
laboratories outside the network and therefore have general
impact on high quality research standards that include also
networking aspects between laboratories, as needed for joint
research approaches.
The RENEB network was established with the aim to significantly increase individual dose reconstruction capacities in
case of large-scale radiological scenarios by pooling resources
and servicing needs. However, the value of RENEB to support
topics also outside emergency preparedness is evident. With
the established strategies to guarantee consistent performance between the partner laboratories, the network has the
ability and capacity to contribute to large-scale research projects with the analysis of exposure biomarkers. Moreover,
RENEB – in combination with an open access database like
STORE (http://storedb.org) – maintains infrastructure for
online-training activities such as image-based scoring of aberrations. Additionally, in case of radiological or nuclear emergencies, it offers secure storing and processing of large

quantities of data for quality assured dose estimation in
radiological incidents.
RENEB ensures maintenance of competence of the actual
and future network partners by providing practical training in
partner laboratories and giving seminars in QA&QM, and
addressing topics according to upcoming needs. While participation in the quality assurance programme of the network
is mandatory for its partners, single training events are also
open to researchers outside the network. This ensures for the
long-term maintenance of competence in the field of biological and physical retrospective dosimetry within the network and a quality assured dissemination of knowledge to a
wider community. It will also be the basis for a good integration of new skilled partners. In addition, RENEB in cooperation with EURADOS contributes to E&T activities in the
European joint programming by providing training courses,
e.g. in cytogenetic and EPR/OSL techniques for students and
researchers, who are interested in biological dosimetry and
physical retrospective dosimetry. Other training programmes
are connected to European nuclear safety/radioprotection
courses and/or international organizations practicing nuclear
safety/radioprotection training, e.g. by inclusion of laboratories of IAEA RANET and WHO BIODOSE in intercomparisons.
Developments of standards and benchmarks for quality
assessment are generally openly accessible.
The long-term development of the biodosimetry network
is assured by implementation of concepts to actively scout
for new techniques and integrate verified methods and new
members in the network. Moreover, a strong link between
RENEB participants and national regulatory authorities is
given by the nature of several partner institutions as governmental agencies or federal offices. Institutions like these will
be able to guarantee the long-term sustainability of the project’s product, the European biodosimetry network. In addition, strong links to the WHO BioDoseNet, REMPAN and IAEA
RANET have been established. This strong connection of
RENEB with the national and international regulatory bodies
will help to consolidate the sustainability of the network.
Besides the promising results achieved so far, the network
partners have to face the daily routine, often outside the
field of emergency and response, and are challenged by
monetary limitations of their institutions. To assure that the
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key aspect of the network remains on the preparedness for a
big radiological or nuclear accident, the network has to
become an integral part of the radiation protection and
emergency preparedness infrastructure at national and/or
international levels. This therefore implies a full and binding
integration of its activities into national and international
operational arrangements. Several RENEB partners are
employees of national radiation protection authorities, and
therefore these partners are best placed to directly transfer
the knowledge about the application of biological and retrospective physical dosimetry and the capabilities of the network to the national authorities. The same is the case for
employees of hospitals, who are able to transfer the knowledge directly to medical centres and likely accident first responders such as ambulance staff. It will be the responsibility
of all partners to actively disseminate the knowledge and
promote the implementation of the network in national and
whenever possible in international emergency preparedness
and response systems.
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